ClinConnect ClinConnect Logo
Search / Trial NCT07034937

Aerobic and Resistance Training in Post-CABG Patients

Launched by UNIVERSITAS PADJADJARAN · Jun 19, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how a combination of aerobic exercise (like walking or cycling) and resistance training using resistance bands can help improve breathing and lung function in people who have recently had heart bypass surgery (also called CABG). The study will focus on how these exercises affect the movement of the diaphragm—the muscle that helps you breathe—and key lung measures like how much air you can blow out and how fast.

To be part of the study, patients need to be between 40 and 65 years old and have had their heart bypass surgery within the past 12 weeks. They should have good vision and hearing and be willing to take part by signing a consent form. People with very high blood pressure, certain injuries that limit movement, or who are receiving other treatments that affect breathing muscles won’t be able to join. If you participate, you’ll be involved in a special exercise program during your cardiac rehabilitation, which aims to help improve your breathing and overall recovery after surgery. This study is not yet recruiting participants but may offer new insights into how exercise can support healing after heart surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients post-CABG surgery maximum 12 weeks after the procedure
  • 2. Age 40-65 years
  • 3. Visual and hearing health
  • 4. Ready to participate in research and sign informed consent.
  • Exclusion Criteria:
  • 1. Blood pressure greater than 160 mmHg for systolic and diastolic blood pressure greater than 100 mmHg
  • 2. Patients with contraindications to aerobic and resistance training, such as fractures that limit movement.
  • 3. Patients undergoing other therapies that may affect diaphragmatic muscle measurement results, such as electrical diaphragmatic stimulation.

About Universitas Padjadjaran

Universitas Padjadjaran, a prestigious academic institution in Indonesia, is dedicated to advancing medical research and clinical trials that contribute to the improvement of healthcare outcomes. With a strong emphasis on interdisciplinary collaboration and innovation, the university harnesses its extensive resources and expertise to conduct rigorous studies aimed at addressing pressing health challenges. Through its commitment to ethical research practices and community engagement, Universitas Padjadjaran plays a pivotal role in fostering evidence-based medicine and enhancing the quality of life for diverse populations.

Locations

Patients applied

0 patients applied

Trial Officials

Dian M Sari, MD., M.Sc., Ph.D

Principal Investigator

Faculty of Medicine Universitas Padjadjaran Bandung

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported